Sulfasalazine Powder
NDC Package 38779-0176-9

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Sulfasalazine powders is sulfasalazine is used to treat a certain type of bowel disease called ulcerative colitis. This formulation utilizes a powder delivery system. Marketed by Medisca Inc., this product is identified by NDC 38779-0176.

Identification & Billing

NDC Package Code
38779-0176-9
Package Description
1000 g in 1 JAR
Product Code
38779-0176
11-Digit Billing Format
38779017609
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
1000 GM

Clinical Specifications

Proprietary Name
Sulfasalazine
Non-Proprietary Name
Sulfasalazine
Substance Name
Sulfasalazine
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
SULFASALAZINE 1 g/g
Usage Information
Sulfasalazine is used to treat a certain type of bowel disease called ulcerative colitis. This medication does not cure this condition, but it helps decrease symptoms such as fever, stomach pain, diarrhea, and rectal bleeding. After an attack is treated, sulfasalazine is also used to increase the amount of time between attacks. This medication works by reducing irritation and swelling in the large intestines. In addition, delayed-release tablets of sulfasalazine are used to treat rheumatoid arthritis. Sulfasalazine helps to reduce joint pain, swelling, and stiffness. Early treatment of rheumatoid arthritis with sulfasalazine helps to reduce/prevent further joint damage so you can do more of your normal daily activities. This medication is used with other drugs, rest, and physical therapy in patients who have not responded to other medications (salicylates, nonsteroidal anti-inflammatory drugs-NSAIDs).

Regulatory & Marketing

Labeler Name
Medisca Inc.
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
07-08-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (38779-0176). Click a package code to view its specific billing and regulatory data.

38779-0176-4
25 g in 1 JAR
38779-0176-5
100 g in 1 JAR
38779-0176-8
500 g in 1 JAR

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 38779-0176-9 identifies a specific commercial package of 1000 g in 1 jar of Sulfasalazine (UNFINISHED drug), a bulk ingredient labeled by Medisca Inc.. This product is billed per "GM" gram and contains an estimated amount of 1000 billable units per package. This powder is formulated for use and contains sulfasalazine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medisca Inc. on July 08, 2014. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Sulfasalazine is used to treat a certain type of bowel disease called ulcerative colitis. This medication does not cure this condition, but it helps decrease symptoms such as fever, stomach pain, diarrhea, and rectal bleeding. After an attack is treated, sulfasalazine is also used to increase the amount of time between attacks. This medication works by reducing irritation and swelling in the large intestines. In addition, delayed-release tablets of sulfasalazine are used to treat rheumatoid arthritis. Sulfasalazine helps to reduce joint pain, swelling, and stiffness. Early treatment of rheumatoid arthritis with sulfasalazine helps to reduce/prevent further joint damage so you can do more of your normal daily activities. This medication is used with other drugs, rest, and physical therapy in patients who have not responded to other medications (salicylates, nonsteroidal anti-inflammatory drugs-NSAIDs).

How is this Medisca Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 38779017609. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 1000 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
38779-0176-9
11-Digit CMS (5-4-2)
38779-0176-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.